F.T.C. Criticizes Agreements That Delay Generic Drugs

September 1, 2011

Some drug makers are using an indirect method to delay competition from low-cost generic products by promising not to introduce their own generic versions if a potential competitor delays its entry into the market, the Federal Trade Commission said in a report on Wednesday. (New York Times)